Hyloris Pharmaceuticals

Liège, Belgium

Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company.

$1.1M raised

Jun 2023

Grant

Biotechnology Health Care Pharmaceutical

Top Investors

Meusinvest (Noshaq)Saffelberg Investments Walloon Scorpiaux

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Hyloris Pharmaceuticals

How much funding has Hyloris Pharmaceuticals raised?

Hyloris Pharmaceuticals has raised $1.1M in total funding. The most recent round was Grant. The last funding was announced in June 2023.

Who are Hyloris Pharmaceuticals's investors?

Hyloris Pharmaceuticals's investors include Meusinvest (Noshaq), Saffelberg Investments, Walloon, Scorpiaux.

Where is Hyloris Pharmaceuticals headquartered?

Hyloris Pharmaceuticals is headquartered in Liège, Belgium.

What does Hyloris Pharmaceuticals do?

Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company.

What stage is Hyloris Pharmaceuticals at?

Hyloris Pharmaceuticals is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 8, 2023.

MLA

"Hyloris Pharmaceuticals — Funding & Investors." VCBacked, June 8, 2023, https://www.vcbacked.co/company/hyloris-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2023). Hyloris Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/hyloris-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Hyloris Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/hyloris-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 8, 2023.